Correlation of Peripheral Blood Inflammatory Indicators to Prognosis After Intravenous Thrombolysis in Acute Ischemic Stroke: A Retrospective Study
Tianrui Zhang,Sha Fu,Xiaofeng Cao,Yangjingyi Xia,Manyan Hu,Qinghua Feng,Yujun Cong,Yuan Zhu,Xiaogang Tang,Minghua Wu
DOI: https://doi.org/10.2147/ijgm.s456144
IF: 2.145
2024-03-15
International Journal of General Medicine
Abstract:Tianrui Zhang, 1, &ast Sha Fu, 1, &ast Xiaofeng Cao, 2 Yangjingyi Xia, 1 Manyan Hu, 1 Qinghua Feng, 1 Yujun Cong, 1 Yuan Zhu, 1 Xiaogang Tang, 1 Minghua Wu 1 1 Department of Neurology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, People's Republic of China; 2 Department of Neurology, Jiangyan Hospital of Chinese Medicine, Taizhou, Jiangsu, 225500, People's Republic of China &astThese authors contributed equally to this work Correspondence: Minghua Wu; Xiaogang Tang, Department of Neurology, Affiliated Hospital of Nanjing University of Chinese Medicine, 155 Hanzhong Road, Nanjing, 210029, People's Republic of China, Tel +8613951786719, Email ; Purpose: According to many previous studies, neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR) and hypersensitive C-reactive protein (CRP) are commonly used as important indicators to assess the prognosis of intravenous thrombolysis in AIS patients. Based on this, we used two novel biomarkers C-NLR (CRP/neutrophil-to-lymphocyte ratio) and C-LMR (CRP×lymphocyte-to-monocyte ratio) to investigate their correlation with 90-day outcomes in AIS patients after intravenous thrombolysis. Patients and Methods: A total of 204 AIS patients who received intravenous thrombolysis at the Stroke Center of Jiangsu Province Hospital of Chinese Medicine from January 2021 to December 2022 were retrospectively included. All patients were followed up 90 days after thrombolysis to assess their prognosis. Patients with a modified Rankin scale score (mRS) of 3– 6 were included in the unfavorable outcome group, and those with a score of 0– 2 were included in the favorable outcome group. Logistic regression analysis, receiver operating characteristic (ROC) curve, and Kaplan–Meier survival curve were used to investigate the association between C-NLR, C-LMR, and 90-day prognosis in AIS patients treated with early intravenous thrombolysis. Results: C-NLR (OR=1.586, 95% CI=1.098~2.291, P=0.014) and C-LMR (OR=1.099, 95% CI=1.025~1.179, P=0.008) were independent risk factors for 90-day prognosis of AIS patients treated with early intravenous thrombolysis. The higher C-NLR and C-LMR were associated with unfavorable prognosis. Conclusion: C-NLR and C-LMR can be used as biomarkers to predict prognosis of AIS patients treated with early intravenous thrombolysis. Keywords: modified rankin scale, reperfusion therapy, inflammatory reaction, cerebral vascular disease, clinical prognosis Acute ischemic stroke is a cerebrovascular disease that seriously threatens life, health, and safety. It is characterized by high disability rate and high fatality rate, and the incidence population shows an expanding trend. 1,2 Clinically, reperfusion therapy is often adopted for AIS patients with a short duration of onset. For example, early rt-PA intravenous thrombolytic therapy for acute ischemic stroke within a time window of 4.5 h has become mainstream practice. 3 Although intravenous thrombolysis can be used as a relatively safe treatment in most cases, it also has many adverse reactions such as intracranial hemorrhage and neurological deterioration. 4 Many studies have focused on early neurological deterioration after intravenous thrombolysis, while the observation of medium and long-term prognosis of intravenous thrombolysis is relatively lacking. 5,6 Considering that rehabilitation of neurological function in the later stage of stroke is also a key link to stroke treatment, our study used the 90-day time point to observe the prognosis of intravenous thrombolysis. Previous studies with a sample from our stroke center had found that inflammatory mechanisms play an important role in the onset and progression of ischemic stroke. 7,8 Other research has confirmed the close correlation between inflammatory factors and neurological deterioration in pathology. 9 NLR has been proven to be an important predictor of stroke prognosis, 10,11 while studies have also confirmed the predictive function of LMR. 12,13 In addition, many studies also used CRP as a joint prediction index. 14–16 Based on these convincing studies, this retrospective study attempted to explore the feasibility of C-NLR and C-LMR in predicting the prognosis of AIS after intravenous thrombolysis on the basis of these indicators. This retrospective cohort study was approved by the Ethics Committee of the Affiliated Hospital of Nanjing University of Chinese Medicine (2017NL-012-01). Informed consent was waived because of retrospe -Abstract Truncated-
medicine, general & internal